首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   154739篇
  免费   2509篇
  国内免费   680篇
化学   88815篇
晶体学   2230篇
力学   5691篇
综合类   5篇
数学   17370篇
物理学   43817篇
  2020年   1112篇
  2019年   1063篇
  2016年   2050篇
  2015年   1669篇
  2014年   2070篇
  2013年   6402篇
  2012年   5070篇
  2011年   6511篇
  2010年   3800篇
  2009年   3444篇
  2008年   5789篇
  2007年   5827篇
  2006年   5863篇
  2005年   5613篇
  2004年   4869篇
  2003年   4381篇
  2002年   4201篇
  2001年   3957篇
  2000年   3037篇
  1999年   2526篇
  1998年   2194篇
  1997年   2200篇
  1996年   2247篇
  1995年   2077篇
  1994年   1820篇
  1993年   1784篇
  1992年   2017篇
  1991年   1976篇
  1990年   1871篇
  1989年   1872篇
  1988年   1901篇
  1987年   1856篇
  1986年   1756篇
  1985年   2470篇
  1984年   2586篇
  1983年   2113篇
  1982年   2506篇
  1981年   2328篇
  1980年   2344篇
  1979年   2316篇
  1978年   2421篇
  1977年   2304篇
  1976年   2299篇
  1975年   2242篇
  1974年   2096篇
  1973年   2299篇
  1972年   1361篇
  1971年   1044篇
  1968年   1084篇
  1967年   1142篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
11.
12.
13.
Su  X. F.  Zhang  Y. L.  Maximov  A. L.  Zhang  K.  Xin  Q.  Feng  C. Q.  Bai  X. F.  Wu  W. 《Russian Journal of Applied Chemistry》2020,93(1):127-136
Russian Journal of Applied Chemistry - Nanoscale ZSM-5 (AlZ5-D) and Ga-substituted ZSM-5 zeolites ((Al,Ga)Z5-D and GaZ5-D) were synthesized by a green dry-gel conversion strategy. For comparison,...  相似文献   
14.
15.
16.
Despite the development of targeted therapies in cancer, the problem of multidrug resistance (MDR) is still unsolved. Most patients with metastatic cancer die from MDR. Transmembrane efflux pumps as the main cause of MDR have been addressed by developed inhibitors, but early inhibitors of the most prominent and longest known efflux pump P-glycoprotein (P-gp) were disappointing. Those inhibitors have been used without knowledge about the expression of P-gp by the treated tumor. Therefore the use of inhibitors of transmembrane efflux pumps in clinical settings is reconsidered as a promising strategy in the case of the respective efflux pump expression. We discovered novel symmetric inhibitors of the symmetric efflux pump MRP4 encoded by the ABCC4 gene. MRP4 is involved in many kinds of cancer with resistance to anticancer drugs. All compounds showed better activities than the best known MRP4 inhibitor MK571 in an MRP4-overexpressing cell line assay, and the activities could be related to the various substitution patterns of aromatic residues within the symmetric molecular framework. One of the best compounds was demonstrated to overcome the MRP4-mediated resistance in the cell line model to restore the anticancer drug sensitivity as a proof of concept.  相似文献   
17.
A photoluminescent bimetallic cluster [Ag10Cu6(bdppthi)2(C≡CPh)12(MeOH)2(H2O)](ClO4)4 ( 1 , bdppthi=N,N’-bis(diphenylphosphanylmethyl)-tetrahydroimidazole} was synthesized from the PNNP type ligand bdppthi generated in-situ. Upon excitation at 365 nm, 1 exhibited strong phosphorescent emission at 630 nm, which was selectively quenched by NH3 in air or water. The sensing of NH3 was rapid and recoverable, with detection limits of 53 ppm (v/v) in N2 and 21 μmol/L (0.36 ppm, w/w) for NH3 ⋅ H2O in water. Cluster 1 could potentially serve as a bifunctional chemical sensor for the efficient detection of ammonia in waste-gas and waste-water.  相似文献   
18.
19.
20.
The dinuclear zinc complex reported by us is to date the most active zinc catalyst for the co‐polymerization of cyclohexene oxide (CHO) and carbon dioxide. However, co‐polymerization experiments with propylene oxide (PO) and CO2 revealed surprisingly low conversions. Within this work, we focused on clarification of this behavior through experimental results and quantum chemical studies. The combination of both results indicated the formation of an energetically highly stable intermediate in the presence of propylene oxide and carbon dioxide. A similar species in the case of cyclohexene oxide/CO2 co‐polymerization was not stable enough to deactivate the catalyst due to steric repulsion.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号